Shire Human Genetic Therapies, Inc., 10% Owner at Translate Bio, Inc. (TBIO), sold 426,334 shares at $19.85 ($8.4M) on 2020-06-01, disclosed to the SEC on 2020-06-03.
Open-market sale of $8.4M TBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.85 | 107,072 | $2.1M | 25.2% |
| 2 | $19.85 | 107,072 | $2.1M | 25.2% |
| 3 | $20.53 | 1,400 | $29K | 0.3% |
| 4 | $19.75 | 100,389 | $2.0M | 23.5% |
| 5 | $19.75 | 100,389 | $2.0M | 23.5% |
| 6 | $20.02 | 5,006 |
| $100K |
| 1.2% |
| 7 | $20.02 | 5,006 | $100K | 1.2% |
| Total | $19.81 avg | 426,334 | $8.4M | 100% |